chr8-106769530-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139166.5(ABRA):c.661C>A(p.Pro221Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139166.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152166Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000121  AC: 3AN: 248480 AF XY:  0.0000224   show subpopulations 
GnomAD4 exome  AF:  0.00000753  AC: 11AN: 1460076Hom.:  0  Cov.: 31 AF XY:  0.0000110  AC XY: 8AN XY: 726182 show subpopulations 
Age Distribution
GnomAD4 genome  0.00000657  AC: 1AN: 152166Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74328 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.661C>A (p.P221T) alteration is located in exon 1 (coding exon 1) of the ABRA gene. This alteration results from a C to A substitution at nucleotide position 661, causing the proline (P) at amino acid position 221 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at